Most Recent Peer-reviewed Publications For Psychosomatic Medicine

A randomized, double-blind, placebo-controlled, dose-ranging study of lisdexamfetamine dimesylate augmentation for major depressive disorder in adults with inadequate response to antidepressant therapy

Post-surgical cerebellar mutism and catatonia

Challenging consultations

Update on medical catatonia: Highlight on delirium

The Neglected Side of Suffering

Adverse Effects of Psychotropic Medications: A Call to Action

Depression During Pregnancy and Postpartum

Guidelines for the Management of Pregnant Women With Substance Use Disorders

The Art and Science of Learning, Teaching, and Delivering Feedback in Psychosomatic Medicine

Economic effects of anti-depressant usage on elective lumbar fusion surgery

Catatonia screening in the general medical setting

The Milestones for Psychosomatic Medicine Subspecialty Training

Levomilnacipran: A newly approved drug for treatment of major depressive disorder

Catatonia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Report of Two Cases and a Review

Is "D" for Depression?

Role of adverse effects in medication nonadherence in bipolar disorder

Cardiovascular adverse effects of newer antidepressants

6 'd's: Next steps after an insufficient antipsychotic response

Psychosocial benefits of a novel mindfulness intervention versus standard support in distressed women with breast cancer

Erratum: Safety and tolerability of levomilnacipran ER in major depressive disorder: Results from an open-label, 48-Week extension study(Clin Drug Investig (2013):33:761-771 DOI 10.1007/s40261-013-0126-5)